Gene Therapy for Phenylketonuria in Adults

AI Insight

This article from the New England Journal of Medicine reports on gene therapy approaches for treating phenylketonuria (PKU) in adult patients. PKU is a genetic metabolic disorder where the body cannot properly break down the amino acid phenylalanine, leading to its toxic accumulation if left untreated. The study examines therapeutic interventions aimed at correcting the underlying genetic defect in mature patients who have lived with dietary management of the condition.

Why it matters

Gene therapy for adult PKU patients could potentially eliminate the need for lifelong restrictive low-protein diets and expensive pharmaceutical treatments. This approach may offer a one-time therapeutic solution that addresses the root genetic cause rather than managing symptoms, improving quality of life for thousands of affected adults worldwide.